Skip to content

Blood Glucose and Insulin Responses to Snack Food Products

A Study to Determine the Effects of Added Ingredients on Glycaemic and Insulinemic Responses to a Snack Food

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01341769
Enrollment
0
Registered
2011-04-26
Start date
2011-04-30
Completion date
2011-07-31
Last updated
2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Study Focus 1:Glycaemic Index, Study Focus 2:Glycaemic Response, Study Focus 3:Insulinemic Response

Brief summary

The purpose of this study is to assess the effects of added food ingredients, when baked into a snack food product, on glycaemic index of the product and glycaemic and insulinemic responses to the product in healthy adults.

Interventions

OTHERDietary Intervention

Sponsors

Reading Scientific Services Ltd.
CollaboratorINDUSTRY
Mondelēz International, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female (not less than 40% males or females * Non-smoker * Aged 18 to 55 years * Have a body mass index between 18.5 to 29.99 kg/m2 * Fasting blood glucose (finger-stick) \>3.3 and \<5.6 mmol/L (Visit 2) * Two-hour OGTT glucose (finger-stick) \<7.8 mmol/L (Visit 2) * Willing and able to provide written informed consent

Exclusion criteria

* Females who are lactating or may be pregnant or if of childbearing potential, are not taking adequate contraceptive precautions * Any significant concurrent illness * History of allergy likely to interfere with the study or known sensitivity to the test food or its ingredients * Have assessed an investigational product for GI in the last 72 hours. * Concurrent participation in any other safety study * History of diabetes, hepatitis, AIDS, anaemia or a heart condition * The use of any medication or dietary supplement which might, in the opinion of the principal investigator 1) make participation in the study dangerous to the subject, or 2) may affect the results. * Had any type of gastrointestinal surgery, including gastric bypass * Having consumed anything apart from plain water in the 12 hours prior to each test * Have been medically diagnosed as having high blood pressure or heart disease

Design outcomes

Primary

MeasureTime frame
Glycaemic index of experimental test foods compared to that of control test food using venous plasma.0-120 minutes

Secondary

MeasureTime frame
Glycaemic index of experimental test foods compared to that of control test food using capillary blood0-120 minutes
Determine and compare glycaemic responses to experimental test foods and control test food using venous plasma and capillary blood0-180 minutes
Measure insulin in venous plasma0-180 minutes
Measure C-peptide in venous plasma0-180 minutes

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026